EMERALD ADVISERS, LLC BBIO Holdings History
EMERALD ADVISERS, LLC's BridgeBio Pharma Inc Holding Summary
As of 2025-03-31, EMERALD ADVISERS, LLC held 1.15 Mil shares of BridgeBio Pharma Inc(BBIO), totaling $39.60 Mil. This investment constitutes 1.78% of their stock portfolio, and EMERALD ADVISERS, LLC now holds 0.6% of the outstanding BridgeBio Pharma Inc(BBIO) stock.
The initial trade took place in 2023Q2. And since then EMERALD ADVISERS, LLC has made 5 purchases of BBIO, at an average price of $22.21, for a total of 1.19 Mil shares. In addition, there have been 3 sales at an average price of $28.57 for 46,577.00 shares. Based on historical transaction data and BBIO's current price of $46.51, EMERALD ADVISERS, LLC's estimated gain on his BBIO holdings is $28.13 Mil, reflecting a 106.22% gain to date.
EMERALD ADVISERS, LLC BBIO ($46.51) Holding Chart
EMERALD ADVISERS, LLC BBIO ($46.51) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
